Ambulance steroid shot aims to slash heart attack deaths
NCT ID NCT07478003
Summary
This large study is testing if giving a powerful anti-inflammatory steroid (methylprednisolone) in the ambulance, right after a major heart attack is diagnosed, can save lives. The goal is to reduce the inflammation that damages the heart when blood flow is restored, which may lower the risk of death and heart failure. Over 5,200 patients with a specific type of severe heart attack (STEMI) will be randomly assigned to receive either the steroid or a placebo shot before they reach the hospital for standard treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STEMI - ST ELEVATION MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aalborg University Hospital
Aalborg, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Odense University Hospital
Odense, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rigshospitalet
Copenhagen, 2100, Denmark
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Skejby, Aarhus University Hospital
Aarhus, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.